Quantitative Imaging and Internal Radiation Dosimetry in the Therapeutic Use of Labeled Monoclonal Antibodies

  • Melvyn J. Myers
Conference paper
Part of the NATO ASI Series book series (NSSA, volume 152)


Before radionuclide immunotherapy can be carried out, the radiation dose to the target and to the normal tissues of the patient ought to be calculated. This is to ensure that the doses involved are likely to destroy the cells of the target while not being of a level likely to harm the patient. The internal radiation dosimetry requires knowledge of the activity in various “sensitive” organs and in the target volume as an absolute measurement in Becquerels. In the past, the term “quantitative” has often been used to signify a numerical estimate of the count or count rate in one part of the body relative to another reference part of the body. While this concept is useful in estimating time changes in activity distributions if the spatial rearrangement of activity is not too gross, it does not fulfill the requirements of estimating the dose received by an organ. Reasons for this include the fact that counts within an area of an image, though obviously related to the activity in the region, are subject to a number of distortions that are characteristic of the imaging equipment used in nuclear medicine. These are discussed in this paper.


Radiation Dose Dose Rate Positron Emitter Tomograph Posterior View Beta Emitter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Benua, R. S., Cicale, N. R. , Sonenberg, M., and Rawson, R. W., 1962, The relation of radioiodine dosimetry to results and complications of metastatic thyroid cancer, Am. J. Roenten., 87:171.Google Scholar
  2. Berger, M. J., 1971, Distribution of absorbed dose around point sources of electrons and beta particles in water and other media, “MIRD Pamphlet No. 5,” Society of Nuclear Medicine, New York.Google Scholar
  3. Eckerman, K. F., 1985, Aspects of the dosimetry of radionuclides within the skeleton with particular emphasis on the active marrow, “Proc. 4th Intl. Radiopharmaceutical Dosimetry Symposium”: 514.Google Scholar
  4. Hosain, F., and Hosain, P., 1978, “Therapy in Nuclear Medicine,” Grune & Stratton, New York.Google Scholar
  5. Kirk, J., Gray, W., and Watson, E. R., 1973, Cumulative radiation effect III: continuous radiation therapy — short lived isotopes, Clin. Rad., 24: 1.CrossRefGoogle Scholar
  6. Loevinger, R. , and Berma, M. , 1968, A schema for absorbed-dose calculations for biologically distributed radionuclides, “MIRD Pamphlet No. 1,” Society of Nuclear Medicine, New York.Google Scholar
  7. Rossi, H. H. , 1985, Microdosimetry and radiobiology, Radiation Protection Dosimetry, 13:245.Google Scholar
  8. Sastry, K. S. R. , Hatdock, C., Basha, A. M. , and Rao, D. V., Electron Dosimetry for radioimmunotherapy: optimal electron energy, Radiation Protection Dosimetry, 13:249.Google Scholar
  9. Snyder, W. S., Ford, M. R. , Warner, G. G. , and Watson, S. B., 1975, “S” absorbed dose per unit cumulated activity for selected radionuclides and organs, “MIRD Pamphlet No. 11,” Society of Nuclear Medicine, New York.Google Scholar
  10. Wu, R. K., and Siegel, J. A., 1983, Absolute quantitation of radioactivity using the build up factor, Med. Phys., 11:189.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Melvyn J. Myers
    • 1
  1. 1.Department of Medical PhysicsHammersmith HospitalLondonUK

Personalised recommendations